 |
Oklahoma State University Center for Health Sciences - College of Osteopathic Medicine | |
| City: Tulsa | State: OK | |
|
Links:
Commentary:This institution participated for the first time this year in the AMSA PharmFree Scorecard. They supplied AMSA with a previously approved policy conflict of interest policy after the submission deadline had passed. This policy is currently being evaluated and the final grade increased from an F to a D.
Updates: This institution did not provide any new or additional for the 2012-13 AMSA PharmFree Scorecard. This institution's evaluation was last updated: 6/29/2012 |
||
| Gifts & Meals |  |
Policy does not adequately address small gifts and does not explicitly discuss on-site meals. |
| Consulting relationships |  |
Policy does cover consulting in its disclosure policy and all consulting relationships are subject to University review. However, there are not specific provisions or frameworks related to creating formal consulting contracts or language to ensure payment is appropriate for tasks. Instead, these issues would be reviewed on an individual basis. |
| Industry-funded speaking relationships | |
Institutional review is required for all potential conflicts of interest, which would include speaking engagements. No explicit discussion of "speaker's bureaus" is included. |
| Disclosure | |
The policy includes an extensive discussion of disclosure policies. However, disclosures are not publically reported and instead are considered confidential. |
| Pharmaceutical samples | |
Samples are not explicitly discussed in this policy. |
| Purchasing & Formularies | |
Employees are required to disclose potential conflicts of interest in purchasing decisions. However, the policy does not explicitly state that committee members with financial conflicts of interest will be forbidden from participating in purchasing decisions. Instead, this would be done on a case-by-case basis. |
| Industry Sales Representatives | |
Policy does not address the presence of industry sales representatives at the school/medical center. |
| On-campus Education | |
This policy does not explicitly address on-site education and industry influence. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
Industry support for travel/off site education would be covered under the disclosure policy, however this type of support is not banned outright. |
| Industry Support for Scholarships & Funds for Trainees |  |
The disclosure policy covers scholarships/trainee funds, however there should be more regulation of these funds written into the policy. |
| Medical school curriculum | |
This policy does not include any details on the school's conflict of interest curriculum. |
| Do the policies specify an oversight mechanism? |  |
The Appropriate Administrator for each employee unit provides oversight. |
| Are there explicit sanctions for noncompliance? | |
Potential consequences are delineated in the policy under the "Consequences of Policy Violations" section. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
